Disease
7 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
SEP 7, 2026 · JOURNAL ARTICLE
Scientific Reports
In vitro mechanistic study demonstrating enhanced probiotic metabolite activity against colorectal cancer cells and angiogenesis, but lacking in vivo efficacy data, clinical endpoints, or human translation.
AUG 18, 2026 · JOURNAL ARTICLE
International Journal of Molecular Sciences
Preclinical organoid study testing drug combinations in vitro; no clinical outcomes, patient data, or in vivo validation reported.
AUG 17, 2026 · JOURNAL ARTICLE
Frontiers in Immunology
Small single-center retrospective cohort (n=22) with univariate analysis only, addressing a rare disease with no established standard, yielding a promising survival signal but explicitly requiring large prospective validation.
AUG 14, 2026 · JOURNAL ARTICLE
Oncology Reports
A comprehensive review synthesizing current molecular classification systems and resistance mechanisms in gastric cancer precision therapy, offering expert perspectives on clinical translation barriers and future directions rather than reporting original trial data.
AUG 10, 2026 · JOURNAL ARTICLE
Biomarker Research
Preclinical mechanistic study in transgenic mice and PDX models with a novel protein delivery approach; no clinical efficacy data or human trials reported, only mechanism validation and proof-of-concept in xenografts.
AUG 10, 2026 · JOURNAL ARTICLE
Frontiers in Oncology
A single case report of an uncommon tumor type with no control group, describing one patient's response and outcome; contributes descriptive data but cannot establish efficacy or guide practice.
JUL 20, 2026 · JOURNAL ARTICLE
Advances in Engineering Technology Research
This is a narrative review synthesizing mechanistic knowledge and preclinical/early-stage gene therapy approaches; it raises research directions rather than reporting a clinical trial result or clinical evidence.